Remove Allergies Remove Dermatology Remove Generic Pharmaceutical Remove Licensing
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. In 2022, Bayer’s revenue in the Pharmaceutical and Consumer Health sectors reached $26.68

Sales 98